Page 157 - 2022 Ranger Medic Handbook
P. 157

ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE (MAALOX)
         Class: Antacid
         Action: Neutralizes gastric acid, increases gastric pH
         Dose: Oral liquid 200mg/200mg/5mL; 10–20mL q6hr prn; max: 80mL/24hr
         Indications: Relief of indigestion, heartburn, and GI upset.
         Contraindications:  Hypersensitivity, renal impairment pregnancy category may use during pregnancy and while
         breastfeeding.
         Adverse/Side-effects: Abdominal cramps, constipation, fecal impaction, nausea, vomiting
         Interactions: May decrease efficacy of most oral medications by inhibiting gastric absorption unless separated by
         2 or more hours.
         Mission Impact: None


         AMOXICILLIN/CLAVULANATE (AUGMENTIN)
         Class: Antimicrobial – antibiotic, aminopenicillin β-lactamase inhibitor  SECTION 4
         Action: Interferes with cell wall replication in certain organisms through osmotic instability and β-lactamase inhibitor
         Dose: PO immediate release: 500mg q8–12hr or 875mg bid; PO extended release: 2,000mg bid
         Indications: Lower respiratory tract infections, otitis media, sinusitis, skin and skin structure infections, urinary tract
         infections, animal bites (dog)
         Contraindications: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions can occur in individuals
         with history of penicillin hypersensitivity; do not use in patients with a history of liver failure; pregnancy category may
         use during pregnancy and while breastfeeding
         Adverse/Side-effects: Diarrhea/loose stools, nausea, skin rashes and urticaria, vomiting, vaginitis, hypersensitivity
         reactions, hepatic dysfunction, blood and lymphatic dysfunction (likely hypersensitivity-related)
         Interactions: May increase effect anticoagulants, decrease effectiveness of oral contraceptives.
         Mission Impact: GROUNDING for personnel on flight status
         K9 Dosage: 10–20mg/kg PO bid × 5–7 days


         ATOVAQUONE-PROGUANIL (MALARONE)
         Class: Antimicrobial; antimalarial
         Dose: Prophylaxis: 250mg/100mg qd; start 1 to 2 days prior to entering a malaria- endemic area, continue throughout
         the stay and for 7 days after returning; Treatment: 1,000mg/400mg qd × 3 days
         Indications: Prophylaxis and treatment of Plasmodium falciparum malaria
         Contraindications: Hypersensitivity to atovaquone or proguanil, renal impairment, pregnancy category avoid use
         during pregnancy and while breastfeeding
         Adverse/Side-effects:  Headache, abdominal pain, nausea, vomiting, diarrhea, dizziness, cough (pediatrics), liver
         transaminase elevations, possible association with seizures and psychotic events (e.g., hallucinations), cutaneous
         reactions, including photosensitivity, erythema multiforme and Stevens-Johnson syndrome
         Mission Impact: None






                                           2022 RANGER MEDIC HANDBOOK  143
   152   153   154   155   156   157   158   159   160   161   162